NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/23/2022
Back to search
Official data from USPTO
CMAX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
08/23/2022
Classification
Registered
Trademark type
Word
Nice classes
1, 5
Filing date
10/30/2019
Registration date
08/23/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/23/2022
Last transaction
08/23/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/11/2021
First use in commerce
10/11/2021
Drawing code
4
Owner type
03
Owner location
Bedford, MA
Examiner
SIMCOX, KYLE DUNCAN
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Conagen Inc.
Representatives
Christina M. Licursi, Esq. WOLF GREENFIELD & SACKS, P.C.
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
biologics, namely, antibodies, and antigens for in vitro scientific or research use, all produced by engineered microbial cells, microbes and/or microbial systems; microbial cells, microbes, and microbial systems for use in the manufacture of biologics including antibodies, antigens, and vaccines
Class 5
biologics, namely, antibodies, antigens, and vaccines all for medical purposes and produced by engineered microbial cells, microbes and/or microbial systems
Publications
History of USPTO decisions and trademark events.
33 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/23/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/22/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/21/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/02/2022
IUAF
USE AMENDMENT FILED
02/25/2022
EISU
TEAS STATEMENT OF USE RECEIVED
02/25/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/03/2021
NOAC
CORRECTED NOA E-MAILED
09/03/2021
EX2G
SOU EXTENSION 2 GRANTED
09/02/2021
DPCC
DIVISIONAL PROCESSING COMPLETE
09/02/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/30/2021
EXT2
SOU EXTENSION 2 FILED
08/25/2021
DRRR
DIVISIONAL REQUEST RECEIVED
08/25/2021
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
08/25/2021
EEXT
SOU TEAS EXTENSION RECEIVED
08/25/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/20/2021
EX1G
SOU EXTENSION 1 GRANTED
02/18/2021
EXT1
SOU EXTENSION 1 FILED
02/18/2021
EEXT
SOU TEAS EXTENSION RECEIVED
02/18/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/25/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/30/2020
PUBO
PUBLISHED FOR OPPOSITION
06/30/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/10/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/26/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/18/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/18/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/18/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/14/2020
GNRT
NON-FINAL ACTION E-MAILED
02/14/2020
CNRT
NON-FINAL ACTION WRITTEN
02/14/2020
DOCK
ASSIGNED TO EXAMINER
02/04/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/04/2019
Continuous trademark protection
Get notified about every new filing that threatens CMAX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.